Applications of multi‐omics analysis in human diseases
MedComm · 2023-08 · 4 (4)
DOI: 10.1002/mco2.315 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 31.07.2023. Verfasst von Chongyang Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Nuclear Medicine Ministry of Health Jiangsu Key Laboratory of Molecular Nuclear Medicine Jiangsu Institute of Nuclear Medicine Wuxi…. Die Arbeit wurde bisher 569-mal zitiert (Crossref) und nennt 307 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Multi‐omics usually refers to the crossover application of multiple high‐throughput screening technologies represented by genomics, transcriptomics, single‐cell transcriptomics, proteomics and metabolomics, spatial transcriptomics, and so on, which play a great role in promoting the study of human diseases. Most of the current reviews focus on describing the development of multi‐omics technologies, data integration, and application to a particular disease; however, few of them provide a comprehensive and systematic introduction of multi‐omics. This review outlines the existing technical categories of multi‐omics, cautions for experimental design, focuses on the integrated analysis methods of multi‐omics, especially the approach of machine learning and deep learning in multi‐omics data integration and the corresponding tools, and the application of multi‐omics in medical researches (e.g., cancer, neurodegenerative diseases, aging, and drug target discovery) as well as the corresponding open‐source analysis tools and databases, and finally, discusses the challenges and future directions of multi‐omics integration and application in precision medicine. With the development of high‐throughput technologies and data integration algorithms, as important directions of multi‐omics for future disease research, single‐cell multi‐omics and spatial multi‐omics also provided a detailed introduction. This review will provide important guidance for researchers, especially who are just entering into multi‐omics medical research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Nuclear Medicine Ministry of Health Jiangsu Key Laboratory of Molecular Nuclear Medicine Jiangsu Institute of Nuclear Medicine Wuxi China.
- Co-innovation Center of Neurodegeneration Nantong University Nantong China.
- Shenzhen Key Laboratory of Modern Toxicology Shenzhen Medical Key Discipline of Health Toxicology (2020-2024) Shenzhen Center for Disease Control and Prevention Shenzhen China.
- Department of Pathophysiology School of Basic Medicine Key Laboratory of Ministry of Education of China and Hubei Province for Neurological Disorders Tongji Medical College Huazhong University of Science and Technology…
ORCID-Profile: Xifei Yang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, C., Wang, J., Pan, D., Wang, X., Xu, Y., Yan, J., Wang, L., Yang, X., Yang, M., & Liu, G. P. (2023). Applications of multi‐omics analysis in human diseases. MedComm, 4(4). https://doi.org/10.1002/mco2.315
Vancouver
Chen C, Wang J, Pan D, Wang X, Xu Y, Yan J, et al. Applications of multi‐omics analysis in human diseases. MedComm. 2023;4(4). doi:10.1002/mco2.315
BibTeX
@article{Chen2023,
author = {Chen, Chongyang and Wang, Jing and Pan, Donghui and Wang, Xinyu and Xu, Yuping and Yan, Junjie and Wang, Lizhen and Yang, Xifei and Yang, Min and Liu, Gong-Ping},
title = {Applications of multi‐omics analysis in human diseases},
journal = {MedComm},
year = {2023},
volume = {4},
number = {4},
doi = {10.1002/mco2.315}
}
EUVIMED